Related Experiment Video
Updated: Nov 17, 2025
07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
829
Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?
Renata de Castro Gonçalves1, Paula Paccielli Freire2, Dario Coletti3,4
1Cancer Metabolism Research Group, Department of Surgery, LIM26-HC, Faculdade de Medicina, and Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Frontiers in Oncology
|February 19, 2021
Summary
Cancer cachexia, marked by muscle loss and inflammation, may stem from faulty autophagy in tumor cells. Restoring autophagy could enhance anti-tumor immunity and combat cachexia symptoms.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Cachexia is a debilitating syndrome in cancer patients, characterized by involuntary skeletal muscle degradation and functional loss.
- It affects 50-80% of cancer patients, worsening with disease progression and negatively impacting quality of life, treatment outcomes, and survival.
- Chronic inflammation and immunosuppression are key features of cachexia, driven by tumor-host interactions involving immune cells.
Purpose of the Study:
- To explore the role of autophagy within the tumor microenvironment in the context of cancer cachexia.
- To investigate the link between dysfunctional autophagy, chronic inflammation, and the development of cachexia.
- To highlight how understanding autophagy's dual role may improve cancer treatment and cachexia management.
Main Methods:
- This review synthesizes current literature on autophagy in the tumor microenvironment and its connection to cancer cachexia.
- Analysis focuses on how autophagy influences immune cell function, cytokine production, and metabolic profiles.
- The study examines the proposed link between impaired autophagic processes in tumor cells and the inflammatory cascade of cachexia.
Main Results:
- Autophagy, a cellular homeostasis process, significantly impacts the tumor microenvironment's metabolic and inflammatory state.
- Balanced autophagy in tumor cells supports immune surveillance and controls inflammation; dysfunctional autophagy promotes an inflammatory phenotype.
- Impaired autophagy in tumor cells may fail to produce immunogenic antigens, hindering anti-tumor immunity and fostering cachexia-related inflammation.
Conclusions:
- Dysfunctional autophagy within the tumor microenvironment is implicated in the chronic inflammation characteristic of cancer cachexia.
- Restoring or modulating autophagic processes in tumor cells could potentially enhance anti-tumor immune responses.
- Targeting autophagy may offer a novel strategy to prevent or mitigate cancer cachexia, improving patient outcomes.
Related Concept Videos
02:17The Tumor Microenvironment
7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
01:27Autophagy
5.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.3K
01:18Autophagic Cell Death
3.7K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.7K
01:36Delivery Pathways to the Lysosome
8.4K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.4K
02:53Adaptive Mechanisms in Cancer Cells
6.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K
03:03mTOR Signaling and Cancer Progression
4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.1K